Kerry Dooley Young
Moderna COVID-19 vaccine wins decisive recommendation from FDA panel
December 18, 2020
The advisers and FDA staff also honed in on several key issues with COVID-19 vaccines, including the challenge of having people in the placebo groups of studies seek to get cleared vaccines.
FDA panel overwhelmingly backs emergency authorization for Pfizer COVID vaccine
December 10, 2020
“I can assure you that no vaccine will be authorized for use in the United States until FDA career officials feel confident in allowing their own families to receive it.”
Medicare finalizes 2021 physician pay rule with E/M changes
December 3, 2020
“This finalized policy marks the most significant updates to E/M codes in 30 years, reducing burden on doctors imposed by the coding system and rewarding time spent evaluating and managing their patients’ care.”
CDC panel delves into priorities for COVID vaccine distribution
November 25, 2020
The meeting served as a forum for experts to discuss the thorny issues ahead.
AMA creates COVID-19 CPT codes for Pfizer, Moderna vaccines
November 13, 2020
AMA plans to introduce more vaccine-specific CPT codes as more vaccine candidates approach FDA review.
CDC panel takes on COVID vaccine rollout, risks, and side effects
November 2, 2020
ACIP will need to offer direction on which groups should get priority in vaccine allocation, inasmuch as early supplies will not be sufficient to vaccinate everyone.
COVID frontline physicians afraid to seek mental health care
October 29, 2020
“The pandemic emphatically underscores our need to change the status quo when it comes to physicians’ mental health,” said Dr. Mark Rosenberg.
COVID-19 vaccine standards questioned at FDA advisory meeting
October 23, 2020
Speakers asked for data showing COVID-19 vaccines can prevent serious illness and urged transparency about the agency’s deliberations for each product to be considered.
FDA posts COVID vaccine guidance amid White House pushback
October 7, 2020
In the new guidance document, FDA officials outline what will be required for even a limited clearance, known as an emergency use authorization, for a COVID-19 vaccine.
‘Celebration’ will be ‘short-lived’ if COVID vaccine rushed: Experts
October 2, 2020
US regulators eventually could safely approve vaccines for COVID-19 if the process is kept free of political pressure regarding time lines, study protocols, and safety standards, expert witnesses told a House panel investigating the process.